Literature DB >> 18516613

Results of total aponeurectomy for Dupuytren's contracture in 61 patients: a retrospective clinical study.

A Högemann1, U Wolfhard, D Kendoff, T N Board, L C Olivier.   

Abstract

INTRODUCTION: Many surgical techniques have been advocated to treat Dupuytren's contracture. Partial fasciectomy is often performed to treat the whole spectrum of Dupuytren's disease.
METHOD: We have reviewed the effectiveness of total aponeurectomy performed on 61 patients [10 women and 51 men (male:female ratio 5.1:1) with a mean age of 63.0 (range 42-79 years) and a mean follow-up of 3.45 years (range 1.03-6.39 years)].
RESULTS: Post-operative complications including haematoma, seroma or necrosis were found in 13.8% of the patients. Recurrence of contracture occurred in 10.8% of the patients and 4.6% of the operated patients presented with a nerve lesion. Nerve irritation occurred in 6.2% of the patients. The mean DASH-score was 3.85 (range 0-52.5). Family pre-disposition was an important risk factor for Dupuytren's disease with 44.3% of patients having a positive family history.
CONCLUSION: We suggest that total aponeurectomy is a promising alternative to partial fasciectomy with low risk for a recurrence and slightly increased risk for a nerve lesion.

Entities:  

Mesh:

Year:  2008        PMID: 18516613     DOI: 10.1007/s00402-008-0657-z

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  7 in total

1.  Psychometric evaluation of the Disabilities of the Arm, Shoulder and Hand (DASH) with Dupuytren's contracture: validity evidence using Rasch modeling.

Authors:  Nancy J Forget; Christina Jerosch-Herold; Lee Shepstone; Johanne Higgins
Journal:  BMC Musculoskelet Disord       Date:  2014-10-30       Impact factor: 2.362

Review 2.  Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Authors:  Catherine Ball; Anna L Pratt; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2013-04-10       Impact factor: 2.362

3.  Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture.

Authors:  Chris Bainbridge; Robert A Gerber; Piotr P Szczypa; Ted Smith; Harvey Kushner; Brian Cohen; Marie-Pierre Hellio Le Graverand-Gastineau
Journal:  J Plast Surg Hand Surg       Date:  2012-06-07

Review 4.  What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice.

Authors:  Anna L Pratt; Catherine Ball
Journal:  BMC Musculoskelet Disord       Date:  2016-01-13       Impact factor: 2.362

5.  The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.

Authors:  Lynn E Murphy; Karen M Murphy; Shauneen M Kilpatrick; Neville W Thompson
Journal:  Ulster Med J       Date:  2017-05-20

6.  Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study.

Authors:  Isam Atroshi; Emelie Strandberg; Anna Lauritzson; Eva Ahlgren; Markus Waldén
Journal:  BMJ Open       Date:  2014-01-15       Impact factor: 2.692

Review 7.  Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren's contracture.

Authors:  C A Peimer; S Wilbrand; R A Gerber; D Chapman; P P Szczypa
Journal:  J Hand Surg Eur Vol       Date:  2014-04-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.